The patents-based pharmaceutical development process: rationale, problems, and potential reforms.

@article{Barton2005ThePP,
  title={The patents-based pharmaceutical development process: rationale, problems, and potential reforms.},
  author={J. Barton and E. Emanuel},
  journal={JAMA},
  year={2005},
  volume={294 16},
  pages={
          2075-82
        }
}
  • J. Barton, E. Emanuel
  • Published 2005
  • Medicine
  • JAMA
  • The pharmaceutical industry is facing substantial criticism from many directions, including financial barriers to access to drugs in both developed and developing countries, high profits, spending on advertising and marketing, and other issues. Underlying these criticisms are fundamental questions about the value of the current patent-based drug development system. Six major problems with the patent system are (1) recovery of research costs by patent monopoly reduces access to drugs; (2) market… CONTINUE READING
    90 Citations

    Topics from this paper

    Value of pharmaceuticals: ensuring the future of research and development.
    • 9
    Australian Pharmaceutical Policy: Price Control, Equity, and Drug Innovation in Australia
    • 17
    Late-stage pharmaceutical R&D and pricing policies under two-stage regulation.
    • 11
    • PDF
    Access to medicines, market failure and market intervention: A tale of two regimes
    • 22
    • PDF
    Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis.
    • 66
    • PDF
    Demythologizing the high costs of pharmaceutical research
    • 165
    • PDF

    References

    SHOWING 1-10 OF 19 REFERENCES
    TRIPS and the global pharmaceutical market.
    • J. Barton
    • Medicine, Economics
    • Health affairs
    • 2004
    • 66
    The price of innovation: new estimates of drug development costs.
    • 3,837
    • PDF
    The changing structure of the pharmaceutical industry.
    • 157
    • PDF
    The pharmaceutical industry--prices and progress.
    • F. Scherer
    • Medicine
    • The New England journal of medicine
    • 2004
    • 125
    • PDF
    Patent Buy-Outs: A Mechanism for Encouraging Innovation
    • 420
    • PDF
    Market structure and drug innovation.
    • 22
    • PDF
    Financing of vaccines
    • 12